Pro-Dex, Inc. - Common Stock (PDEX)

Pro-Dex (PDEX) Q1 FY2026 earnings crush estimates, with revenue and EPS beating forecasts. Stock surges on strong results and a major investment gain.

A fundamental analysis of (NASDAQ:PDEX): Why PRO-DEX INC (NASDAQ:PDEX) qualifies as a high growth stock.

A fundamental analysis of (NASDAQ:PDEX): PRO-DEX INC (NASDAQ:PDEX) showing high EPS and FCF growth while beating expectations

Pro-Dex Inc (NASDAQ:PDEX): A Strong Candidate for Little Book Investors

A fundamental analysis of (NASDAQ:PDEX): PRO-DEX INC (NASDAQ:PDEX) is a candidate for growth investors. Here's why.

A fundamental analysis of (NASDAQ:PDEX): PRO-DEX INC (NASDAQ:PDEX) is a candidate for growth investors. Here's why.

Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level.

PDEX stock results show that Pro-Dex missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.

Although the equities sector saw some impressive gains this year, there’s still time for undervalued stocks with strong growth potential.

A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Here is a closer look at some medical stock opportunities that may be revealed by analyzing these patterns.